Filing Details

Accession Number:
0001209191-16-119740
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-05-13 09:30:15
Reporting Period:
2016-05-12
Filing Date:
2016-05-13
Accepted Time:
2016-05-13 09:30:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1029142 Dynavax Technologies Corp DVAX Pharmaceutical Preparations (2834) 330728374
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1580849 Robert Janssen C/O Dynavax Technologies
2929 Seventh Street, Suite 100
Berkeley CA 94710
Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-05-12 1,000 $15.12 1,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. This price reflects the price for an open-market purchase of shares of Common Stock made by Robert Janssen on May 12, 2016.